Frank S. Menniti

Frank S.
Menniti was the founder of Cadent Therapeutics, Inc., founded in 2010, where the title held was Chief Scientific Officer.
Dr. Menniti was the founder of Mindimmune Therapeutics, Inc., founded in 2016, where the title held was Chief Science Officer & Director.
Dr. Menniti completed undergraduate education at Franklin & Marshall College, graduate education at Massachusetts Institute of Technology, and doctorate education at The University of North Carolina at Asheville.